ESC 365 - Tailoring drug therapy in medical device treated Heart failure patients - Benefit of PAP monitoring.

Open Access

Tailoring drug therapy in medical device treated Heart failure patients - Benefit of PAP monitoring.

Session: What did change in Heart Failure patient management since the last EHRA?

Topic: Device Therapy

Speaker: Doctor A. Flett (London, GB)

Sponsored by ABBOTT

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Andrew Flett

The Heart Hospital, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

8 more presentations in this session

Introduction.

Speaker: Professor J. Steffel (Zurich, CH)

Novel treatment options in Heart Failure management: Implications for daily clinical practice enhancement.

Speaker: Professor J. Steffel (Zurich, CH)

How innovation can help in optimizing your CRT in 2021.

Speaker: Doctor N. Rivas-Gandara (Barcelona, ES)

Live Q&A.

Changing the course of heart failure – impact of transcatheter mitral & tricuspid repair therapies.

Speaker: Professor C. Butter (Bernau bei Berlin, DE)

Access the full session

What did change in Heart Failure patient management since the last EHRA?

Speakers: Doctor A. Flett, Professor J. Steffel, Professor J. Steffel, Doctor N. Rivas-Gandara, Professor C. Butter

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources